Effect of additional administration of pertuzumab for the post-treatment in patients with HER2-positive locally advanced/metastatic breast cancer who were previously treated with pertuzumab.

Shinichiro Kubo

Effect of additional administration of pertuzumab for the post-treatment in patients with HER2-positive locally advanced/metastatic breast cancer who were previously treated with pertuzumab.

2019

Shinichiro Kubo

e12500Background: Currently, there are no data related to re-administering trastuzumab (T) + pertuzumab (P) beyond the second-line therapy to patients with human epidermal growth factor receptor 2-...

Keywords:

Trastuzumab
Pathology
Oncology
Pertuzumab
Medicine
Internal medicine
Metastatic breast cancer
Human Epidermal Growth Factor Receptor 2
locally advanced
post treatment
in patient
previously treated

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations